MOREPEN LABORATORIES LTD

MOREPEN LABORATORIES LTD (India) holds 32 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 27 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “MOREPEN LABORATORIES LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/morepen-laboratories-ltd

Overview

MOREPEN LABORATORIES LTD is an active pharmaceutical ingredient (API) supplier with 31 active FDA Type II Drug Master Files, covering APIXABAN; APIXABAN AMORPHOUS; APIXABAN FORM H3; ATORVASTATIN CALCIUM TRIHYDRATE; BEMPEDOIC ACID; BREXPIPRAZOLE.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which MOREPEN LABORATORIES LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

MOREPEN LABORATORIES LTD holds 32 active (35 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • FINERENONE (ROUTE-II)Active2026-05-25
  • BEMPEDOIC ACIDActive2025-12-12
  • RUPATADINE FUMARATEActive2025-11-22
  • VORTIOXETINE HYDROBROMIDE (ROUTE-II)Active2025-09-05
  • BREXPIPRAZOLEActive2024-12-02
  • TICAGRELORActive2024-08-27
  • VONOPRAZAN FUMARATEActive2023-01-05
  • ERTUGLIFLOZIN L-PYROGLUTAMATEActive2022-07-26
  • DAPAGLIFLOZIN AMORPHOUSActive2022-03-14
  • VORTIOXETINE HYDROBROMIDEActive2022-01-31
  • APIXABAN AMORPHOUSActive2021-12-27
  • OLMESARTAN MEDOXOMILActive2021-12-02
  • RIVAROXABANActive2021-08-28
  • LINAGLIPTIN FORM CActive2021-08-18
  • EDOXABAN TOSYLATEActive2021-07-02
  • APIXABAN FORM H3Active2021-05-03
  • APIXABANActive2021-03-27
  • SAXAGLIPTIN HYDROCHLORIDE DIHYDRATEActive2021-02-27
  • SITAGLIPTIN PHOSPHATE ANYDROUSActive2020-12-31
  • DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATEActive2020-03-18
  • LINAGLIPTINActive2019-10-04
  • EMPAGLIFLOZINActive2019-07-06
  • SAXAGLIPTIN HYDROCHLORIDEActive2019-02-27
  • SITAGLIPTIN PHOSPHATE MONOHYDRATEActive2019-01-17
  • ROSUVASTATIN CALCIUMActive2018-11-26
  • ROSUVASTATIN CALCIUM PROCESS -2Active2018-03-12
  • FEXOFENADINE HYDROCHLORIDE USPActive2016-06-27
  • ATORVASTATIN CALCIUM TRIHYDRATEActive2012-08-23
  • MONTELUKAST SODIUMActive2010-12-13
  • LORATADINE (PROCESS 2) U.S.P.Active2007-07-11
  • DESLORATADINEActive2004-09-07
  • LORATADINEActive1997-09-11
  • ATORVASTATIN CALCIUM AMORPHOUS, BULK SUBSTANCEInactive2005-06-06
  • ATORVASTATIN CALCIUMInactive2005-02-23
  • PIOGLITAZONE HYDROCHLORIDEInactive2004-09-23

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to MOREPEN LABORATORIES LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to MOREPEN LABORATORIES LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this MOREPEN LABORATORIES LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.